Translating Innovation in Discovery through Collaboration Symposium
Moderators- Zhong Zhong, PhD, VP Biology, Wave Life Sciences,Christopher Horvath, DVM, MS, DACVP, SVP Preclinical Development, Bluebird Bio

8:30-9:00 - Breakfast

9:00-9:15 - Welcome and Introductions; Mark Nedelman, CEO Biomere

9:15-9:50 - “Of Monkeys and Men: A Translational Approach to Studying Innate Immunity in HIV Infection.”
R. Keith Reeves, PhD, Assistant Professor of Medicine, Harvard Medical School, Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center

9:55-10:30 - "Preclinical drug development for infectious diseases." James Whitney, PhD, Assistant Professor of Medicine, Harvard Medical School, Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center and Ragon Institute of MGH, MIT, and Harvard

10:30-11:00 - Break

11:00-11:35 -“Building a bridge across the species barrier: immunoglobulin biology in rhesus macaques and humans.” Margie Ackerman, PhD, Assistant Professor of Engineering, Thayer School of Engineering at Dartmouth College.

11:40-12:15 - "Innovative medicines for lipid and protein accumulation in brain cells." Penny Hallet, Director, Neuroregeneration Institute, McLean Hospital / Harvard Medical School.

12:15-1:10 - Lunch

1:15-1:55 - “Translating Gene Therapy for Neurological Disorders from bench to bedside: collaborations between scientists and physician scientists are essential.” Guangping Gao, PhD, Professor, Microbiology & Physiology Systems, Penelope Booth Rockwell Professor in Biomedical Research, Director, Horae Gene Therapy Center and Vector Core, UMass Medical School

2:00-2:35 - "Translating Novel Genetic Medicines Technology: A Hybrid of Collaborative Networks and Internal Focus.” Albert Seymour, PhD, Chief Scientific Officer, Homology Medicines

2:40-3:00 - Break

3:00-3:35 -“Discovery and Development of AAV Gene Therapies for CNS Disorders.” Dinah Sah, PhD, Senior Vice-President of Neuroscience, Voyager Therapeutic

3:40-4:15 - “Ocular Drug Development: Preclinical Safety Challenges.” Vito Sasseville, DVM, PhD,
Preclinical Safety TA Head Ophthalmology and ID and NIDU, Head, Discovery and Investigative Pathology, Novartis

4:15-4:30 - Wrap up/questions

***Limited registration, so be sure to reserve your spot early! Lunch and breakfast will be provided***

**100% of ticket sales will be donated to retired animal sanctuaries for NHPs**

Cosponsors:

Ora Clinical, Inc. : http://www.oraclinical.com

MBI (Massachusetts Biotechnology Inniatives) : http://www.massbiomed.org